Paraneoplastic syndromes: The way to an early diagnosis of lung cancer

Pneumologia

Volumn 64, Issue 2, 2015, Pages 14-19

  Paraschiv, Bianca ^a   Diaconu, Camelia C ^b   Toma, Claudia L ^a,b   Bogdan, Miron A ^a,b  

^a Marius Nasta Institute of Pneumology   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Lung cancer; Paraneoplastic syndrome

Indexed keywords

CARCINOMA, SMALL CELL; COMPLICATION; EARLY DIAGNOSIS; HUMAN; LUNG NEOPLASMS; MORTALITY; PARANEOPLASTIC ENDOCRINE SYNDROMES; PARANEOPLASTIC SYNDROMES; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PROGNOSIS;

CARCINOMA, SMALL CELL; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; PARANEOPLASTIC ENDOCRINE SYNDROMES; PARANEOPLASTIC SYNDROMES; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PROGNOSIS;

EID: 84936940261     PISSN: 20672993     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Gaga M, Powell C, Schraufnagel D, et all. An Official American Thoracic Society/European Respiratory Society Statement. The role of the pulmonologist in the diagnosis and management of lung cancer. Am J RespirCrit Care Med. 2013; 188(4):503-7.
2. Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology and prevention. Clin Chest Med. 2011; 32(4):10.
3. Beckles MA, Spiro SG, Colice GL, et all. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests and paraneoplastic Syndromes. Chest. 2003; 123:97S-104S.
4. Früh M, de Ruysscher D, Popa Set all. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2013; 24(6): vi99S-vi105S.
5. Senties H, Vega-Boada F. Paraneoplastic syndromes associated with anti-Hu antibodies. IMAJ.2001; 3:94-103.
6. Heinemann S, Zabel P, Hauber HP. Paraneoplastic syndromes in lung cancer. Cancer Therapy. 2008; 6:687-98.
7. Pelosof LC,Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc. 2010; 85(9):838-54.
8. Dalmau J, Rosenfeld MR. Overview of paraneoplastic syndromes of the nervous system. www.uptodate.com (accessed December 2014).
9. Horwitz MJ. Hypercalcemia of malignancy. www.uptodate.com (accessed Deceember2014).
10. Lorch G, Viatchenko-Karpinski S, Ho HT et all. The calcium-sensing receptor is necessary for the rapid development of hypercalcemia in human lung squamous cell carcinoma. Neoplasia. 2011; 13:428-38.
11. Hermes A,Waschk B, Reck M. Hyponatremia as prognostic factor in small cell lung cancer - a retrospective single institution analysis. Respiratory Medicine. 2012; 106:900-04.
12. Diaconu CC, Arsene D, Paraschiv B et all. Hyponatremic encephalopathy as the initial sign of neuroendocrine small cell carcinoma: case report. ActaEndocrinologica. 2013; 9(4):637-42.
13. Petereit C, Zaba O, Teber I et all. A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan. BMC Pulmonary Medicine. 2013; 13:55.
14. Ejaz S, Vassilopoulou-Sellin R, Busaidy NL et all. Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion. Cancer. 2011; 117(19):4381-89.
15. Yu KH, Wu YJ, Kuo CF et all. Survival analysis of patients with dermatomyositis and polymyositis. Clinical Rheumatology. 2011; 30(12):1595-601.
16. Wu F, Su C, Liu Let all. Hyperpigmentation in palms associated with lung adenocarcinoma resolving after chemotherapy. ClinRespir J. 2014. epub ahead of print.
17. Podjasek JO, Wetter DA, Pittelkow MR et all. Cutaneous small-vessel vasculitis associated with solid organ malignancies: The Mayo Clinic experience, 1996 to 2009. Journal of the American Academy of Dermatology. 2012; 66 (2):e55-e65.
18. Dalmau J, Rosenfeld MR. Paraneoplastic syndromes affecting peripheral nerve and muscle. www.uptodate.com (accessed December 2014).
19. Le Roy A, Pasquier P, Savard Det all. Paraneoplastic granulocytosis in an advanced lung cancer patient. Ann BiolClin. 2014;72(3):367-70.
20. Stathopoulos GP, Armakolas A, Tranga T et all.Granulocyte colony-stimulating factor expression as a prognostic biomarker in non-small cell lung cancer. Oncology Reports. 2011; 25 (6):1541-44.
21. Kim M, Chang H, Yang HCet all. Preoperative thrombocytosis is a significant unfavorable prognostic factor for patients with resectable non-small cell lung cancer. World J SurgOncol. 2014; 12:37.
22. Lin RJ, Afshar-Kharghan V, Schafer AI. Paraneoplastic thrombocytosis: the secrets of tumor self-promotion. Blood. 2014; 124(2):184-87.
23. Corrales-Rodriguez L, Blais N. Lung cancer associated venous thromboembolic disease: a comprehensive review. Lung Cancer. 2012; 75(1):1-8.
24. Graus F, Delattre JY, Antoine JC et all. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J NeurolNeurosurg Psychiatry. 2004; 75:1135-40.
25. Giometto B, Grisold W, Vitaliani Ret all. Paraneoplastic neurologic syndrome in the PNS Euronetwork Database: an European Study from 20 centers. Arch Neurol. 2010;67(3):330-335.
26. Vedeler CA, Antoine JC, Giometto B et all. Paraneoplastic neurological syndromes. European Handbook of Neurological Management. 2011; 1(31):447-57.
27. Dalmau J, Rosenfeld MR. Paraneoplastic syndromes affecting the spinal cord and dorsal root ganglia. www.uptodate.com (accessed December 2014)